Myasthenia Gravis

Diagnosis and management.

Reviewed by Dr Kola Tytler MBBS CertHE MBA MSt MRCGP (General Practitioner)

Last reviewed: 21 October 2025

Neurology

Turn this into CPDPractise this topic, identify learning gaps and prepare a CPD draft you can review.

Clinical Guidelines

NICE Technology Appraisal Guidance [TA1069]: Efgartigimod for treating antibody-positive generalised myasthenia gravis

NICE Technology Appraisal Guidance [TA940]: Eculizumab for treating refractory myasthenia gravis

Suspected neurological conditions: recognition and referral (NICE guideline NG127)

Guideline for the management of myasthenic syndromes

International Consensus Guidance for Management of Myasthenia Gravis: 2020 Update

International Consensus Guidance for Management of Myasthenia Gravis: 2020 Update

International Consensus Guidance for Management of Myasthenia Gravis: 2020 Update

The Japanese clinical guidelines 2022 for myasthenia gravis and Lambert–Eaton myasthenic syndrome